Lmr Partners LLP Gilead Sciences, Inc. Transaction History

Lmr Partners LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $1.68 Million - $2.42 Million	27,016 New	27,016 $2.32 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $2.28 Million - $2.56 Million	-39,437 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $2.28 Million - $2.86 Million	39,437 New	39,437 $2.35 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $5.14 Million - $5.84 Million	-79,258 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $5.36 Million - $5.79 Million	79,258 New	79,258 $5.54 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $734,400 - $837,950	-12,240 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $307,269 - $350,119	-5,424 Reduced 30.71%	12,240 $713,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $3.64 Million - $4.58 Million	-58,638 Reduced 76.85%	17,664 $1.12 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $777,076 - $902,328	10,742 Added 16.38%	76,302 $5.87 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $4.11 Million - $5.26 Million	65,560 New	65,560 $4.98 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $2.88 Million - $3.16 Million	-46,668 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $2.92 Million - $3.22 Million	46,668 New	46,668 $2.96 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.